Definitive Contract HHSN261201100014C
Award Date
7/1/11
Potential Completion Date
6/30/16
Potential Value
$10M
Federal Agency
National Cancer Institute
Awardee
Mayo Clinic
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Rochester, MN 55905, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
15
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Mayo Clinic, a renowned non-profit academic medical center. The $39,597,204.00 contract is for early-stage therapeutic development with a Phase II emphasis. The contract does not have a set-aside designation. Under this contract, Mayo Clinic will provide research and development services to support preclinical pharmacokinetic and pharmacology evaluations of...
The National Cancer Institute (NCI) awarded a $1,956,302.92 cost-no-fee delivery order contract to Mayo Clinic for core infrastructure support for the Cancer Prevention Agent Development Program. This contract supports the NCI's Experimental Therapeutics program, enabling Mayo Clinic to conduct preclinical pharmacokinetic and pharmacology evaluations of cancer therapeutic agents from lead selection through early clinical trials. The contract has a performance period through September 2023 and is...
This federal contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Mayo Clinic, a renowned non-profit academic medical center. The $806,712.00 contract is for the provision of "CORE INFRASTRUCTURE SUPPORT" under the "CLINICAL PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH" major program. The contract is a Delivery Order with a Cost No Fee pricing type. Mayo Clinic is supporting the NCI's...
This is a firm-fixed price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Mayo Clinic, a renowned non-profit academic medical center. The contract is for $1,603.00 and covers pre-clinical pharmacokinetic and pharmacology evaluations of cancer therapeutic agents being developed under the NCI's Experimental Therapeutics program. This work supports the transition of promising cancer treatments from the laboratory to early...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a delivery order contract worth $3,665,424.78 to the Mayo Clinic, a large non-profit academic medical center focused on integrated clinical practice, education, and research. The contract is to provide core infrastructure support for the Cancer Prevention Agent Development Program's Early Phase Clinical Research efforts. This award is not a set-aside contract. Mayo Clinic has extensive...
This federal contract award, valued at $1,070.00, was issued by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center, to provide contract orientation and kick-off meeting support for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract titled "Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients." The contract is structured as a firm-fixed price delivery order and does not have a...
This federal contract award, valued at $259,490.16, was issued by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center. The contract provides "Core Infrastructure Support" and is classified as a Delivery Order with a Cost No Fee pricing type. The award does not have a set-aside designation. Mayo Clinic holds a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the NCI, valued at up to $9.9 million, to provide...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a delivery order contract to Mayo Clinic, a large non-profit academic medical center, to provide core infrastructure support services. The $658,179.00 contract does not have a set-aside designation and is part of the Cancer Prevention Agent Development Program: Early Phase Clinical Research major program. Mayo Clinic will implement bioanalytical methods, conduct pharmacokinetic...
This is a delivery order awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Mayo Clinic, a large non-profit academic medical center. The five-year, $204,622.95 contract supports pharmacokinetic and bioavailability studies of selected anticancer compounds in mice, which will provide analytical support to the NCI's Experimental Therapeutics program. Mayo Clinic is conducting these preclinical evaluations under a larger $9.9 million...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $218,370.00 firm fixed-price delivery order contract to Mayo Clinic, a large non-profit academic medical center, for "Pharmacokinetic Studies with Selected Anticancer Compounds in NSG Mice." The period of performance is September 13, 2019 through September 12, 2024. This delivery order is issued under the Pharmacokinetic and Pharmacology Evaluations for Cancer Patients...